HeartFlow

HeartFlow, founded in 2007, is a pioneering medical technology company dedicated to transforming the diagnosis and management of coronary artery disease. By integrating advanced artificial intelligence with computational fluid dynamics, the firm provides non-invasive, three-dimensional diagnostic software that assists healthcare professionals in precision heart care. The company operates at the intersection of big data and clinical diagnostics, offering a unique, AI-driven approach to cardiovascular disease management that distinguishes it from traditional imaging providers.

The organization maintains a robust operational footprint with a workforce of 500-1,000 employees focused on engineering, software development, and clinical research. This multidisciplinary team drives the innovation behind their mission-critical medical devices and digital health platforms. Meet HeartFlow's team to understand the leadership and technical expertise fueling their ongoing development of interactive diagnostic tools. Their commitment to precision medicine is supported by a history of strategic funding rounds, enabling the continuous evolution of their proprietary diagnostic software and educational programs for clinicians worldwide.

HeartFlow, listed under the ticker NASDAQ: HTFL, continues to expand its market presence through strategic partnerships and technological advancements. With annual revenue reaching $191.4M, the company demonstrates significant scale within the medical technology sector. Explore financial highlights to review detailed metrics regarding their funding history and fiscal performance. By leveraging high-performance computing and real-time data analysis, HeartFlow remains a leader in the competitive landscape of cardiovascular diagnostics, consistently pushing the boundaries of non-invasive heart care technology.